The current approach to esophageal function testing is deemed insufficient for accurately characterizing esophageal motility disorders, particularly in patients with…
Browsing: Clinical Updates
A phase 1 trial for a vaccine targeting micrometastatic disease markers in patients treated for pancreatic or colorectal cancer has…
A study conducted by the Mayo Clinic, which provides reassurance about the low rate of pulmonary aspiration during upper gastrointestinal…
The US Food and Drug Administration (FDA) has declined to approve Astellas’s investigational gastric/gastroesophageal junction cancer drug, zolbetuximab, due to…
A recent study published in “Annals of Oncology” by a French research group has made significant strides in precision medicine…
Early detection of Barrett’s esophagus neoplasia is vital, managed through surveillance and BET (including EMR, ESD, RFA), but challenges like…
Throughout 2023, gastroenterology societies introduced several significant clinical practice updates for the diagnosis, management, and treatment of various gastrointestinal (GI)…
This study sheds light on the complex interplay between race, ethnicity, and cancer treatment outcomes, underscoring the importance of personalized…
The article from Nature, presents a study on the relationship between endoscopic healing (EH) and the effectiveness of biologic treatments…
In patients with inflammatory bowel disease, neither biologics nor small molecule targeted therapies increase the risk for major adverse cardiac…